Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Umbilical cord mesenchymal stem cells in knee osteoarthritis
NCT03383081Phase 2Recruiting
- Sponsor
- Sclnow Biotechnology Co., Ltd.
- Start
- Oct 2018
- Primary completion
- Jun 2026
- Modality
- Cell Therapies
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of iSCLife-OA in osteoarthritis (OA) (3 arms), sponsored by Sclnow Biotechnology Co., Ltd. Primary endpoint: Kellgren-Lawrence Grading Scale at 12 months. Started Oct 2018; status: recruiting.
02
Drugs
iSCLife-OA
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT03383081.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03383081.